• Je něco špatně v tomto záznamu ?

Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humans

JA. Hubacek, M. Jirsa, M. Bobak, D. Pelclova, S. Zakharov,

. 2018 ; 94 (5) : 445-449. [pub] 20180718

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045386

Grantová podpora
NV16-27075A MZ0 CEP - Centrální evidence projektů

As the susceptibility of humans to xenobiotics often depends on genetic factors, we assumed that ADH1B and ALDH2 genetic variants may affect susceptibility to the acute methanol exposure. To evaluate the role of genetic variants of enzymes involved in methanol catabolism in humans, we analysed ADH1B (rs1229984) and ALDH2 (rs441) polymorphisms in 50 adults who survived acute methanol poisoning, 246 individuals with alcoholic liver cirrhosis, and in 545 healthy controls. GG homozygotes of ADH1B were more common among methanol-poisoned patients (98%) and among patients with alcoholic liver cirrhosis (98%) than among healthy controls (90%) (P = 0.08 and < 0.001, respectively). Minor C allele carriers of the ALDH2 were significantly more common among methanol-poisoned persons (46%) than among patients with alcoholic liver cirrhosis or healthy controls (31% in both groups, P < 0.05 and 0.025, respectively); the odds ratios were 1.89 (95% CI 1.02-3.52) and 1.94 (1.08-3.48), respectively. As there was a substantial amount of subjects with alcohol abuse between both groups of patients, ADH1B is unlikely to affect the susceptibility to methanol poisoning. By contrast, the genetic variant of the ALDH2 enzyme seems to specifically affect the susceptibility to methanol in acutely exposed humans and potentially plays a role in the outcome of methanol poisoning.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045386
003      
CZ-PrNML
005      
20200113134522.0
007      
ta
008      
200109s2018 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cge.13411 $2 doi
035    __
$a (PubMed)29968299
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Hubacek, J A $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    10
$a Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humans / $c JA. Hubacek, M. Jirsa, M. Bobak, D. Pelclova, S. Zakharov,
520    9_
$a As the susceptibility of humans to xenobiotics often depends on genetic factors, we assumed that ADH1B and ALDH2 genetic variants may affect susceptibility to the acute methanol exposure. To evaluate the role of genetic variants of enzymes involved in methanol catabolism in humans, we analysed ADH1B (rs1229984) and ALDH2 (rs441) polymorphisms in 50 adults who survived acute methanol poisoning, 246 individuals with alcoholic liver cirrhosis, and in 545 healthy controls. GG homozygotes of ADH1B were more common among methanol-poisoned patients (98%) and among patients with alcoholic liver cirrhosis (98%) than among healthy controls (90%) (P = 0.08 and < 0.001, respectively). Minor C allele carriers of the ALDH2 were significantly more common among methanol-poisoned persons (46%) than among patients with alcoholic liver cirrhosis or healthy controls (31% in both groups, P < 0.05 and 0.025, respectively); the odds ratios were 1.89 (95% CI 1.02-3.52) and 1.94 (1.08-3.48), respectively. As there was a substantial amount of subjects with alcohol abuse between both groups of patients, ADH1B is unlikely to affect the susceptibility to methanol poisoning. By contrast, the genetic variant of the ALDH2 enzyme seems to specifically affect the susceptibility to methanol in acutely exposed humans and potentially plays a role in the outcome of methanol poisoning.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a alkoholismus $x komplikace $x etiologie $7 D000437
650    _2
$a mitochondriální aldehyddehydrogenasa $x genetika $7 D000071396
650    _2
$a alely $7 D000483
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a jaterní cirhóza $x etiologie $x patologie $7 D008103
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methanol $x škodlivé účinky $x otrava $7 D000432
650    _2
$a lidé středního věku $7 D008875
650    _2
$a odds ratio $7 D016017
650    12
$a farmakogenomické varianty $7 D000071184
650    12
$a polymorfismus genetický $7 D011110
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jirsa, M $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Bobak, M $u International Institute for Health and Society, Department of Epidemiology and Public Health, University College London, London, UK.
700    1_
$a Pelclova, D $u Toxicological Information Center, Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Zakharov, S $u Toxicological Information Center, Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
773    0_
$w MED00001127 $t Clinical genetics $x 1399-0004 $g Roč. 94, č. 5 (2018), s. 445-449
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29968299 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113134855 $b ABA008
999    __
$a ok $b bmc $g 1483655 $s 1084059
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 94 $c 5 $d 445-449 $e 20180718 $i 1399-0004 $m Clinical genetics $n Clin Genet $x MED00001127
GRA    __
$a NV16-27075A $p MZ0
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace